title: A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome.
abstract: POTS (postural tachycardia syndrome) is a chronic form of OI (orthostatic intolerance). Neuropathic POTS is characterized by decreased adrenergic vasoconstriction, whereas hyperadrenergic POTS exhibits increased adrenergic vasoconstriction. We hypothesized that midodrine, an α1-adrenergic receptor agonist, would increase CVR (calf vascular resistance), decrease C(v) (calf venous capacitance) and decrease orthostatic tachycardia in neuropathic POTS, but not alter haemodynamics in hyperadrenergic POTS. A total of 20 POTS patients (12 neuropathic and eight hyperadrenergic), ages 12-20 years, participated in this randomized placebo-controlled double-blind cross-over study. Of these subjects, 15 were female. POTS subjects received 2 weeks of treatment with midodrine or placebo, with increased dosing from 2.5 to 10 mg three times daily. Following a 7-day drug-washout period, subjects received the cross-over treatment. HR (heart rate), MAP (mean arterial pressure), Q(calf) (calf blood flow) and CVR were measured supine and during 35° HUT (head-up tilt). C(v) was measured supine. In neuropathic POTS, midodrine decreased supine HR, Q(calf) and C(v), while increasing MAP and CVR compared with placebo. During HUT, in neuropathic POTS, midodrine decreased HR, Q(calf) and C(v), while increasing MAP and CVR. In hyperadrenergic POTS, placebo and midodrine both decreased upright HR and increased supine CVR. Placebo also increased supine C(v), compared with midodrine in hyperadrenergic POTS. Therefore midodrine improved postural tachycardia in neuropathic POTS by increasing CVR and decreasing Q(calf) and C(v), whereas these effects were not seen in hyperadrenergic POTS patients who experienced a placebo effect. This suggests that midodrine is probably an effective treatment for neuropathic POTS, but not for hyperadrenergic POTS.
authors: *Department of Behavioral Biology, Johns Hopkins University, Baltimore, MD 21218, U.S.A.
authors: Amanda J
authors: AJ
authors: Ross
authors: Anthony J
authors: AJ
authors: Ocon
authors: Marvin S
authors: MS
authors: Medow
authors: Julian M
authors: JM
authors: Stewart
mesh_terms: D000293:Adolescent; D000328:Adult; D001794:Blood Pressure / Q000502:physiology; D002648:Child; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D008297:Male; D008879:Midodrine / Q000008:administration & dosage / Q000627:therapeutic use*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy*; D015990:Placebo Effect; D054972:Postural Orthostatic Tachycardia Syndrome / Q000188:drug therapy*; D013610:Tachycardia / Q000188:drug therapy; D016896:Treatment Outcome; D014661:Vasoconstriction / Q000187:drug effects*; D055815:Young Adult
chemical_list: D008879:Midodrine
references: Clin Auton Res. 2006 Dec;16(6):390-5
references: 17036177
references: Pacing Clin Electrophysiol. 2009 Feb;32(2):234-8
references: 19170913
references: Brain Res Brain Res Rev. 2001 Mar;35(1):1-19
references: 11245883
references: Expert Rev Cardiovasc Ther. 2012 Nov;10(11):1387-99
references: 23244360
references: Indian Pacing Electrophysiol J. 2006 Apr 01;6(2):84-99
references: 16943900
references: Circulation. 2005 May 31;111(21):2734-40
references: 15911704
references: JAMA. 1997 Apr 2;277(13):1046-51
references: 9091692
references: JAMA. 1975 Jun 23;232(12):1225-7
references: 1173382
references: J Appl Physiol (1985). 2012 Nov;113(10):1659-68
references: 22678960
references: Circulation. 2005 Oct 25;112(17):2611-8
references: 16230486
references: Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2749-56
references: 12919934
references: Circulation. 2002 Dec 3;106(23):2946-54
references: 12460877
references: Circulation. 2009 Sep 1;120(9):725-34
references: 19687359
references: J Cardiovasc Electrophysiol. 2009 Mar;20(3):352-8
references: 19207771
references: Circulation. 2008 May 27;117(21):2814-7
references: 18506020
references: Pediatrics. 2013 May;131(5):968-80
references: 23569093
references: J Physiol. 1997 Sep 1;503 ( Pt 2):463-7
references: 9306287
references: J Pediatr. 2012 Feb;160(2):222-6
references: 21996154
references: Circulation. 1998 Nov 17;98(20):2154-9
references: 9815870
references: Circ J. 2011;75(4):927-31
references: 21301135
references: Clin Auton Res. 2000 Feb;10(1):29-33
references: 10750641
references: Circulation. 2002 May 14;105(19):2274-81
references: 12010910